147 related articles for article (PubMed ID: 34846787)
1. Treatment of hypertension with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and resting metabolic rate: A cross-sectional study.
Pedrianes-Martin PB; Martin-Rincon M; Morales-Alamo D; Perez-Suarez I; Perez-Valera M; Galvan-Alvarez V; Curtelin D; de Pablos-Velasco P; Calbet JAL
J Clin Hypertens (Greenwich); 2021 Dec; 23(12):2106-2114. PubMed ID: 34846787
[TBL] [Abstract][Full Text] [Related]
2. The use of renin-angiotensin-aldosterone system (RAAS) inhibitors is associated with a lower risk of mortality in hypertensive COVID-19 patients: A systematic review and meta-analysis.
Wang Y; Chen B; Li Y; Zhang L; Wang Y; Yang S; Xiao X; Qin Q
J Med Virol; 2021 Mar; 93(3):1370-1377. PubMed ID: 33095513
[TBL] [Abstract][Full Text] [Related]
3. Resting metabolic rate is increased in hypertensive patients with overweight or obesity: Potential mechanisms.
Pedrianes-Martin PB; Perez-Valera M; Morales-Alamo D; Martin-Rincon M; Perez-Suarez I; Serrano-Sanchez JA; Gonzalez-Henriquez JJ; Galvan-Alvarez V; Acosta C; Curtelin D; de Pablos-Velasco P; Calbet JAL
Scand J Med Sci Sports; 2021 Jul; 31(7):1461-1470. PubMed ID: 33749940
[TBL] [Abstract][Full Text] [Related]
4. The Number of Pills, Rather Than the Type of Renin-Angiotensin System Inhibitor, Predicts Ambulatory Blood Pressure Control in Essential Hypertensives on Triple Therapy: A Real-Life Cross-Sectional Study.
Sarzani R; Giulietti F; Filipponi A; Marziali S; Ristori L; Buscarini S; Garbuglia C; Biondini S; Allevi M; Spannella F
Adv Ther; 2021 Jul; 38(7):4013-4025. PubMed ID: 34115328
[TBL] [Abstract][Full Text] [Related]
5. Observational Study of Brain Atrophy and Cognitive Decline Comparing a Sample of Community-Dwelling People Taking Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Over Time.
Moran C; Xie K; Poh S; Chew S; Beare R; Wang W; Callisaya M; Srikanth V
J Alzheimers Dis; 2019; 68(4):1479-1488. PubMed ID: 30909218
[TBL] [Abstract][Full Text] [Related]
6. Effect of Renin-Angiotensin system inhibition on cardiovascular events in older hypertensive patients with metabolic syndrome.
Zreikat HH; Harpe SE; Slattum PW; Mays DP; Essah PA; Cheang KI
Metabolism; 2014 Mar; 63(3):392-9. PubMed ID: 24393433
[TBL] [Abstract][Full Text] [Related]
7. Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Hypertensive Patients with COVID-19 (COVIDECA Study).
Mustafic H; Fayssoil A; Josseran L; Ouadahi M; Grimaldi-Bensouda L; Dubourg O; Annane D; Mansencal N
Am J Cardiol; 2021 May; 147():58-60. PubMed ID: 33617818
[TBL] [Abstract][Full Text] [Related]
8. Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19.
Zhang P; Zhu L; Cai J; Lei F; Qin JJ; Xie J; Liu YM; Zhao YC; Huang X; Lin L; Xia M; Chen MM; Cheng X; Zhang X; Guo D; Peng Y; Ji YX; Chen J; She ZG; Wang Y; Xu Q; Tan R; Wang H; Lin J; Luo P; Fu S; Cai H; Ye P; Xiao B; Mao W; Liu L; Yan Y; Liu M; Chen M; Zhang XJ; Wang X; Touyz RM; Xia J; Zhang BH; Huang X; Yuan Y; Loomba R; Liu PP; Li H
Circ Res; 2020 Jun; 126(12):1671-1681. PubMed ID: 32302265
[TBL] [Abstract][Full Text] [Related]
9. A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan.
Wu LS; Chang SH; Chang GJ; Liu JR; Chan YH; Lee HF; Wen MS; Chen WJ; Yeh YH; Kuo CT; See LC
Cardiovasc Diabetol; 2016 Apr; 15():56. PubMed ID: 27039185
[TBL] [Abstract][Full Text] [Related]
10. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
Talbert RL
J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
[TBL] [Abstract][Full Text] [Related]
11. Plasma aldosterone is increased in class 2 and 3 obese essential hypertensive patients despite drug treatment.
Sarzani R; Guerra F; Mancinelli L; Buglioni A; Franchi E; Dessì-Fulgheri P
Am J Hypertens; 2012 Jul; 25(7):818-26. PubMed ID: 22552267
[TBL] [Abstract][Full Text] [Related]
12. Effects of ACEi and ARB on post-exercise hypotension induced by exercises conducted at different times of day in hypertensive men.
Brito LC; Azevêdo L; Peçanha T; Fecchio RY; Rezende RA; da Silva GV; Pio-Abreu A; Mion D; Halliwill JR; Forjaz CLM
Clin Exp Hypertens; 2020 Nov; 42(8):722-727. PubMed ID: 32589058
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARBs) may be safe for COVID-19 patients.
Wang W; Zhao X; Wei W; Fan W; Gao K; He S; Zhuang X
BMC Infect Dis; 2021 Jan; 21(1):114. PubMed ID: 33494713
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-Receptor Blocker, Angiotensin-Converting Enzyme Inhibitor, and Risks of Atrial Fibrillation: A Nationwide Cohort Study.
Hsieh YC; Hung CY; Li CH; Liao YC; Huang JL; Lin CH; Wu TJ
Medicine (Baltimore); 2016 May; 95(20):e3721. PubMed ID: 27196491
[TBL] [Abstract][Full Text] [Related]
15. [Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients].
Hanon O; Laroche P; Vidal JS; Pannier B; Postel-Vinay N; Vaisse B; Girerd X
Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):218-23. PubMed ID: 22695025
[TBL] [Abstract][Full Text] [Related]
16. Influence of hospitalisation on the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in elderly hypertensive patients.
Wawruch M; Slezakova V; Murin J; Luha J; Bozik M; Leitmann T; Kuzelova M; Shah R
Aging Clin Exp Res; 2014 Jun; 26(3):307-14. PubMed ID: 24781831
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin receptor blockers (ARB) outperform angiotensin-converting enzyme (ACE) inhibitors on ischemic stroke prevention in patients with hypertension and diabetes - A real-world population study in Taiwan.
Pai PY; Muo CH; Sung FC; Ho HC; Lee YT
Int J Cardiol; 2016 Jul; 215():114-9. PubMed ID: 27111172
[TBL] [Abstract][Full Text] [Related]
18. Urocortin 2 in patients with hypertension treated with angiotensin converting enzyme inhibitors or angiotensin receptor blockers.
Walczewska J; Siga O; Dzieza-Grudnik A; Krolczyk J; Wizner B; Wolkow PP; Borys A; Kolton-Wroz M; Gryglewska B; Grodzicki T
J Physiol Pharmacol; 2019 Apr; 70(2):. PubMed ID: 31443094
[TBL] [Abstract][Full Text] [Related]
19. Development and Validation of a Medication Selection Model Under Clinical Application of Renin-Angiotensin Inhibitor Combined with Calcium Channel Blocker for Hypertension Patients.
Hong D; Shi W; Lu X; Lou Y; Li L
Med Sci Monit; 2020 Apr; 26():e923696. PubMed ID: 32285846
[TBL] [Abstract][Full Text] [Related]
20. EVALUATING THE PRESCRIPTION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS OR RECEPTOR BLOCKERS IN PATIENTS WITH DIABETES IN JORDAN.
Mayyas F; Bataineh W; Jarab A
Endocr Pract; 2017 Nov; 23(11):1289-1296. PubMed ID: 28816537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
